Saitama, Japan

Hiromu Murofushi


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:

goldMedal1 out of 832,912 
Other
 patents

Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiromu Murofushi: Innovator in Cancer Research

Introduction

Hiromu Murofushi is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of cancer research through his innovative work in synthesizing novel compounds. His dedication to advancing medical science is evident in his patent portfolio.

Latest Patents

Murofushi holds a patent for a carba cyclic phosphatidic acid derivative. This invention aims to synthesize a compound with a unique structure by substituting oxygen at position sn-2 of the glycerol skeleton with carbon. The derivative is designed to suppress cancer cell invasion, showcasing its potential therapeutic applications. The compound is represented by a specific formula, where R denotes various alkyl, alkenyl, or alkynyl groups, and M represents a hydrogen atom or counter cation.

Career Highlights

Throughout his career, Murofushi has focused on innovative solutions to complex medical challenges. His work has garnered attention for its potential impact on cancer treatment. With a patent count of 1 patent, he continues to explore new avenues in pharmaceutical research.

Collaborations

Murofushi has collaborated with notable colleagues, including Kimiko Murofushi and Mutsuko Mukai. These partnerships have contributed to the advancement of his research and the development of new therapeutic strategies.

Conclusion

Hiromu Murofushi is a dedicated inventor whose work in synthesizing carba cyclic phosphatidic acid derivatives holds promise for cancer treatment. His innovative approach and collaborative efforts highlight the importance of research in combating serious health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…